Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) (FMS) closed at $22.22 on November 11, 2026, down 2.3% from the previous close, on volume of 4,508,105 shares (30-day average 1,263,133).
Data as of November 11, 2026.
Fresenius SE cuts Fresenius Medical Care stake to 20%
Seeking Alpha News (Thu, 12-Nov 6:59 AM ET)
DZ BANK AG Sticks to Their Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
TipRanks (Wed, 11-Nov 5:06 AM ET)
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from Jefferies
TipRanks (Tue, 10-Nov 2:25 AM ET)
Fresenius Medical Care Places €500 Million Bond
TipRanks (Mon, 9-Nov 4:49 PM ET)
Barclays downgrades Fresenius Medical Care AG & Co. KGaA (0H9X) to a Sell
TipRanks (Mon, 9-Nov 3:15 AM ET)
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Hold from Goldman Sachs
TipRanks (Mon, 9-Nov 2:35 AM ET)
Fresenius Medical Care narrows 2026 outlook as one-time China costs weigh on reported profits
Market Chameleon (Tue, 3-Nov 4:17 AM ET)
PRNewswire (Tue, 3-Nov 7:00 AM ET)
PRNewswire (Wed, 21-Oct 6:13 PM ET)
PRNewswire (Mon, 19-Oct 9:01 AM ET)
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) trades on the NYSE stock market under the symbol FMS.
As of November 12, 2026, FMS stock price declined to $21.73 with 1,442,998 million shares trading.
FMS has a beta of 0.16, meaning it tends to be less sensitive to market movements. FMS has a correlation of 0.01 to the broad based SPY ETF.
FMS has a market cap of $11.67 billion. This is considered a Large Cap stock.
Last quarter Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) reported $6 billion in Revenue and $.64 earnings per share. This fell short of revenue expectation by $-208 million and missed earnings estimates by -$.07.
In the last 3 years, FMS traded as high as $30.46 and as low as $17.49.
The top ETF exchange traded funds that FMS belongs to (by Net Assets): PZLV, AVDE, APIE, TIIV, CVAR.
FMS has underperformed the market in the last year with a price return of -5.8% while the SPY ETF gained +12.4%. FMS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.0% and -3.9%, respectively, while the SPY returned -1.1% and -1.5%, respectively.
FMS support price is $21.82 and resistance is $22.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FMS shares will trade within this expected range on the day.
